Valproic acid prevents penile fibrosis and erectile dysfunction in cavernous nerve-injured rats

Journal of Sexual Medicine

Volumn 11, Issue 6, 2014, Pages 1442-1451

  Hannan, Johanna L ^a   Kutlu, Omer ^b   Stopak, Bernard L ^a   Liu, Xiaopu ^a   Castiglione, Fabio ^c   Hedlund, Petter ^c,d   Burnett, Arthur L ^a   Bivalacqua, Trinity J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Cavernous nerve; Erectile dysfunction; Factor beta; Fibrosis; Histone deacetylase; Transforming growth

Indexed keywords

ACTIN ANTIBODY; ALPHA SMOOTH MUSCLE ACTIN; FIBRONECTIN; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; TRANSFORMING GROWTH FACTOR BETA1; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILATERAL CAVERNOUS NERVE INJURY; CAVERNOUS NERVE STIMULATION; CONTROLLED STUDY; ERECTILE DYSFUNCTION; HEMODYNAMICS; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IN VIVO STUDY; INTRACAVERNOSAL PRESSURE; MALE; NERVE INJURY; NERVE STIMULATION; NONHUMAN; PENILE FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SMOOTH MUSCLE; TREATMENT DURATION; UROGENITAL SYSTEM PARAMETERS; WESTERN BLOTTING;

CAVERNOUS NERVE; ERECTILE DYSFUNCTION; FACTOR BETA; FIBROSIS; HISTONE DEACETYLASE; TRANSFORMING GROWTH;

ANIMALS; BLOTTING, WESTERN; ERECTILE DYSFUNCTION; FIBROSIS; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; MALE; PENILE ERECTION; PENILE INDURATION; PENIS; PROSTATECTOMY; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; TRAUMA, NERVOUS SYSTEM; VALPROIC ACID;

EID: 84901982069     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12522     Document Type: Article

References (46)

1. Burnett AL. Erectile dysfunction following radical prostatectomy. JAMA 2005;293:2648-2653.
2. Mulhall JP. Penile rehabilitation following radical prostatectomy. Curr Opin Urol 2008;18:613-620.
3. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003;169:1175-1179.
4. Zhou F, Li GY, Gao ZZ, Liu J, Liu T, Li WR, Cui WS, Bai GY, Xin ZC. The TGF-beta1/Smad/CTGF pathway and corpus cavernosum fibrous-muscular alterations in rats with streptozotocin-induced diabetes. J Androl 2012;33:651-659.
5. Hu WL, Hu LQ, Song J, Li SW, Zheng XM, Cheng B, Tian BC. Fibrosis of corpus cavernosum in animals following cavernous nerve ablation. Asian J Androl 2004;6:111-116.
6. Canguven O, Lagoda G, Sezen SF, Burnett AL. Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats. J Urol 2009;181:2816-2822.
7. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005;173:1673-1676.
8. Angeloni NL, Bond CW, McVary KT, Podlasek CA. Sonic hedgehog protein is decreased and penile morphology is altered in prostatectomy and diabetic patients. PLoS ONE 2013;14:e70985.
9. Burnett AL. Strategies to promote recovery of cavernous nerve function after radical prostatectomy. World J Urol 2003;20:337-342.
10. Khan AU, Krishnamurthy S. Histone modifications as key regulators of transcription. Front Biosci 2005;10:866-872.
11. Fuks F. DNA methylation and histone modifications: Teaming up to silence genes. Curr Opin Genet Dev 2005;15:490-495.
12. Cavasin MA, Demos-Davies K, Horn TR, Walker LA, Lemon DD, Birdsey N, Weiser-Evans MC, Harral J, Irwin DC, Anwar A, Yeager ME, Li M, Watson PA, Nemenoff RA, Buttrick PM, Stenmark KR, McKinsey TA. Selective class I histone deacetylase inhibition suppresses hypoxia-Induced cardiopulmonary remodeling through an antiproliferative mechanism. Circ Res 2012;110:739-748.
13. Guo W, Shan B, Klingsberg RC, Qin X, Lasky JA. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. Am J Physiol Lung Cell Mol Physiol 2009;297:L864-870.
14. Van Beneden K, Mannaerts I, Pauwels M, Van den Branden C, van Grunsven LA. HDAC inhibitors in experimental liver and kidney fibrosis. Fibrogenesis Tissue Repair 2013;6:1-14.
15. Lee HA, Lee DY, Cho HM, Kim SY, Iwasaki Y, Kim IK. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension. Circ Res 2013;112:1004-1012.
16. Liu F, Levin MD, Petrenko NB, Lu MM, Wang T, Yuan LJ, Stout AL, Epstein JA, Patel VV. Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. J Mol Cell Cardiol 2008;45:715-723.
17. Zhang ZZ, Gong YY, Shi YH, Zhang W, Qin XH, Wu XW. Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush. Neuroscience 2012;224:282-293.
18. Bang WS, Kim KT, Cho DC, Kim HJ, Sung JK. Valproic acid increases expression of neuronal stem/progenitor cell in spinal cord injury. J Korean Neurosurg Soc 2013;54:8-13.
19. Hannan JL, Albersen M, Kutlu O, Gratzke C, Stief CG, Burnett AL, Lysiak JJ, Hedlund P, Bivalacqua TJ. Inhibition of Rho-kinase improves erectile function, increases nitric oxide signaling and decreases penile apoptosis in a rat model of cavernous nerve injury. J Urol 2013;189:1155-1161.
20. Bivalacqua TJ, Diner EK, Novak TE, Vohra Y, Sikka SC, Champion HC, Kadowitz PJ, Hellstrom WJ. A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol 2000;163:1992-1998.
21. Pang M, Kothapally J, Mao H, Tolbert E, Ponnusamy M, Chin YE, Zhuang S. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 2009;297:F996-1005.
22. Marumo T, Hishikawa K, Yoshikawa M, Hirahashi J, Kawachi S, Fujita T. Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol 2010;298:F133-141.
23. Lee TM, Lin MS, Chang NC. Inhibition of histone deacetylase on ventricular remodeling in infarcted rats. Am J Physiol Heart Circ Physiol 2007;293:H968-977.
24. Canguven O, Burnett A. Cavernous nerve injury using rodent animal models. J Sex Med 2008;5:1776-1785.
25. Albersen M, Fandel TM, Lin G, Wang G, Banie L, Lin CS, Lue TF. Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med 2010;7:3331-3340.
26. Burnett AL, Becker RE. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury. J Urol 2004;171:495-500.
27. Quinlan DM, Nelson RJ, Partin AW, Mostwin JL, Walsh PC. The rat as a model for the study of penile erection. J Urol 1989;141:656-661.
28. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, Abdel-Mageed AB, Hellstrom WJ. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003;24:239-245.
29. Vignozzi L, Filippi S, Morelli A, Marini M, Chavalmane A, Fibbi B, Silvestrini E, Mancina R, Carini M, Vannelli GB, Forti G, Maggi M. Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism. J Sex Med 2009;6:1270-1283.
30. Advani A, Huang Q, Thai K, Advani SL, White KE, Kelly DJ, Yuen DA, Connelly KA, Marsden PA, Gilbert RE. Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism. Am J Pathol 2011;178:2205-2214.
31. Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int 2008;101:203-210.
32. Lysiak JJ, Yang SK, Klausner AP, Son H, Tuttle JB, Steers WD. Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. J Urol 2008;179:779-785.
33. Vignozzi L, Filippi S, Morelli A, Ambrosini S, Luconi M, Vannelli GB, Donati S, Crescioli C, Zhang XH, Mirone V, Forti G, Maggi M. Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. J Sex Med 2006;3:419-431.
34. Kovanecz I, Rivera S, Nolazco G, Vernet D, Segura D, Gharib S, Rajfer J, Gonzalez-Cadavid NF. Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage. J Sex Med 2012;9:2814-2826.
35. Jin HR, Chung YG, Kim WJ, Zhang LW, Piao S, Tuvshintur B, Yin GN, Shin SH, Tumurbaatar M, Han JY, Ryu JK, Suh JK. A mouse model of cavernous nerve injury-induced erectile dysfunction: Functional and morphological characterization of the corpus cavernosum. J Sex Med 2010;7:3351-3364.
36. Shin TY, Ryu JK, Jin HR, Piao S, Tumurbaatar M, Yin GN, Shin SH, Kwon MH, Song KM, Fang ZH, Han JY, Kim WJ, Suh JK. Increased cavernous expression of transforming growth factor-beta1 and activation of the Smad signaling pathway affects erectile dysfunction in men with spinal cord injury. J Sex Med 2011;8:1454-1462.
37. Watanabe T, Tajima H, Hironori H, Nakagawara H, Ohnishi I, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Tani T, Fujimura T, Ota T, Wakayama T, Iseki S, Harada S. Sodium valproate blocks the transforming growth factor (TGF)-beta1 autocrine loop and attenuates the TGF-beta1-induced collagen synthesis in a human hepatic stellate cell line. Int J Mol Med 2011;28:919-925.
38. Liu N, He S, Ma L, Ponnusamy M, Tang J, Tolbert E, Bayliss G, Zhao TC, Yan H, Zhuang S. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. PLoS ONE 2013;8:e54001.
39. Noh H, Oh EY, Seo JY, Yu MR, Kim YO, Ha H, Lee HB. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol 2009;297:F729-739.
40. Pelzel HR, Schlamp CL, Nickells RW. Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis. BMC Neurosci 2010;11:62.
41. Rivieccio MA, Brochier C, Willis DE, Walker BA, D'Annibale MA, McLaughlin K, Siddiq A, Kozikowski AP, Jaffrey SR, Twiss JL, Ratan RR, Langley B. HDAC6 is a target for protection and regeneration following injury in the nervous system. Proc Natl Acad Sci U S A 2009;106:19599-19604.
42. Cui SS, Yang CP, Bowen RC, Bai O, Li XM, Jiang W, Zhang X. Valproic acid enhances axonal regeneration and recovery of motor function after sciatic nerve axotomy in adult rats. Brain Res 2003;975:229-236.
43. Fei W, Aixi Y, Danmou X, Wusheng K, Zhengren P, Ting R. The mood stabilizer valproic acid induces proliferation and myelination of rat Schwann cells. Neurosci Res 2011;70:383-390.
44. Tan J, Cang S, Ma Y, Petrillo RL, Liu D. Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol 2010;3:5-18.
45. Sidana A, Wang M, Shabbeer S, Chowdhury WH, Netto G, Lupold SE, Carducci M, Rodriguez R. Mechanism of growth inhibition of prostate cancer xenografts by valproic acid. J Biomed Biotechnol 2012;2012:180363.
46. Stettner M, Kramer G, Strauss A, Kvitkina T, Ohle S, Kieseier BC, Thelen P. Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer. Eur J Cancer Prev 2012;21:55-64.